Get App Open
In App
Lending
Lending
Open App

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Nov 14, 16:01
1227.95 19.10 (1.58%)
Volume
AVERAGE VOLUME
5-Day
62,059
10-Day
70,026
30-Day
46,388
49,980
  • Prev. Close

    1208.85

  • Open Price

    1210.05

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Nov 14, 15:59
1222.50 12.30 (1.02%)
Volume
AVERAGE VOLUME
5-Day
1,646,750
10-Day
1,816,597
30-Day
1,377,933
2,055,973
  • Prev. Close

    1210.20

  • Open Price

    1210.20

  • Bid Price (Qty.)

    1222.50 (562)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Key Financial Ratios of Aurobindo Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
Per Share Ratios  
Basic EPS (Rs.) 29.97 33.35 21.00 24.83 53.13  
Diluted EPS (Rs.) 29.97 33.35 21.00 24.83 53.13  
Cash EPS (Rs.) 35.19 37.70 28.43 31.92 61.46  
Book Value [ExclRevalReserve]/Share (Rs.) 353.55 336.62 305.75 292.15 271.80  
Book Value [InclRevalReserve]/Share (Rs.) 353.55 336.62 305.75 292.15 271.80  
Dividend / Share(Rs.) 0.00 4.50 3.00 9.00 4.00  
Revenue from Operations/Share (Rs.) 188.25 181.70 218.34 192.65 270.07  
PBDIT/Share (Rs.) 49.68 48.47 36.95 36.60 80.38  
PBIT/Share (Rs.) 44.57 44.13 29.52 29.51 72.05  
PBT/Share (Rs.) 40.61 41.01 27.55 27.95 71.57  
Net Profit/Share (Rs.) 30.08 33.35 21.00 24.83 53.13  
Profitability Ratios  
PBDIT Margin (%) 26.39 26.67 16.92 18.99 29.76  
PBIT Margin (%) 23.67 24.28 13.51 15.31 26.67  
PBT Margin (%) 21.57 22.57 12.61 14.50 26.49  
Net Profit Margin (%) 15.97 18.35 9.61 12.88 19.67  
Return on Networth / Equity (%) 8.50 9.90 6.86 8.49 19.54  
Return on Capital Employed (%) 12.27 12.98 9.47 9.92 25.69  
Return on Assets (%) 6.34 7.76 4.93 6.73 13.42  
Total Debt/Equity (X) 0.23 0.14 0.23 0.11 0.25  
Asset Turnover Ratio (%) 0.42 0.43 0.55 0.50 0.74  
Liquidity Ratios  
Current Ratio (X) 1.20 1.38 1.46 2.35 1.83  
Quick Ratio (X) 0.83 0.93 0.84 1.55 1.12  
Inventory Turnover Ratio (X) 4.63 1.77 1.94 1.41 1.58  
Dividend Payout Ratio (NP) (%) 0.00 13.49 35.71 18.12 7.52  
Dividend Payout Ratio (CP) (%) 0.00 11.93 26.38 14.10 6.50  
Earnings Retention Ratio (%) 0.00 86.51 64.29 81.88 92.48  
Cash Earnings Retention Ratio (%) 0.00 88.07 73.62 85.90 93.50  
Valuation Ratios  
Enterprise Value (Cr.) 71,682.11 66,554.38 34,360.05 40,961.62 55,216.93  
EV/Net Operating Revenue (X) 6.56 6.25 2.69 3.63 3.49  
EV/EBITDA (X) 24.84 23.43 15.87 19.10 11.72  
MarketCap/Net Operating Revenue (X) 6.16 6.00 2.37 3.47 3.26  
Retention Ratios (%) 0.00 86.50 64.28 81.87 92.47  
Price/BV (X) 3.28 3.24 1.69 2.29 3.24  
Price/Net Operating Revenue 6.16 6.00 2.37 3.47 3.26  
Earnings Yield 0.03 0.03 0.04 0.04 0.06  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Outskill Genai